Analyst Research

Report Title Price
Provider: GlobalData
$125.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

EU Regulators May Fine Ranbaxy Laboratories Ltd-Business Standard


Monday, 3 Jun 2013 11:19am EDT 

Business Standard reported that Ranbaxy Laboratories Ltd declined to comment on the reports from Brussels that European Union anti-trust regulators may fine the domestic pharma company for allegedly blocking of entry of cheaper generic medicines in the market. Reports said that Ranbaxy was among the nine companies that are to fined for the allegedly blocking the entry of the generic medicines in the EU. 

Company Quote